The KPC type β-lactamases: New enzymes that confer resistance to carbapenems in Gram-negative bacilli

Folia Histochemica et Cytobiologica

Volumn 47, Issue 4, 2009, Pages 537-543

  Sacha, Paweł ^a   Ostas, Alina ^b   Jaworowska, Jadwiga ^c   Wieczorek, Piotr ^a   Ojdana, Dominika ^a   Ratajczak, Jerzy ^b   Tryniszewska, Elzbieta ^a  

^a MEDICAL UNIVERSITY OF BIALYSTOK   (Poland)

^b INSTITUTE OF HEMATOLOGY AND TRANSFUSION MEDICINE   (Poland)

^c University Hospital of Bialystok   (Poland)

Author keywords

Epidemiology; KPC type carbapenemases; Molecular genetics

Indexed keywords

AZTREONAM; BETA LACTAM ANTIBIOTIC; BETA LACTAMASE INHIBITOR; BETA LACTAMASE SHV; BETA LACTAMASE TEM 1; CARBAPENEM DERIVATIVE; CARBAPENEMASE; CEFTAZIDIME; CEPHALOSPORIN DERIVATIVE; CLAVULANIC ACID; DORIPENEM; ERTAPENEM; GENTAMICIN; IMIPENEM; MEROPENEM; NXL 104; PENICILLIN DERIVATIVE; POLYMYXIN B; QUINOLINE DERIVED ANTIINFECTIVE AGENT; TAZOBACTAM; TIGECYCLINE; TOBRAMYCIN; UNCLASSIFIED DRUG;

ACINETOBACTER; AMINO ACID SEQUENCE; ANTIBIOTIC RESISTANCE; ARTICLE; BACTERIAL GENE; BACTERIAL GENETICS; ENTEROBACTERIACEAE; ENZYME STRUCTURE; GENE IDENTIFICATION; GRAM NEGATIVE BACTERIUM; HUMAN; KLEBSIELLA OXYTOCA; KLEBSIELLA PNEUMONIAE; MULTIDRUG RESISTANCE; NONHUMAN; NUCLEOTIDE SEQUENCE; PSEUDOMONAS AERUGINOSA;

ACINETOBACTER; ANIMALIA; BACILLI (CLASS); ENTEROBACTERIACEAE; NEGIBACTERIA; PSEUDOMONAS AERUGINOSA;

EID: 77954401318     PISSN: 02398508     EISSN: None     Source Type: Journal    
DOI: 10.2478/v10042-009-0079-y     Document Type: Article

References (75)

1. Rodloff AC, Goldstein EJ, Torres A. Two decades of imipenem therapy. J Antimicrob Chemother. 2006;58(5):916-929.
2. Dalhoff A, Janjic N, Echols R. Redefining penems. Biochem Pharmacol. 2006 30;71(7):1085-1095.
3. Cao VB, Arlet G, Ericsson BM, Tammelin A, Courvalin P, Lambert T. Emergence of imipenem resistance in Klebsiella pneumoniae owing to combination of plasmid-mediated CMY-4 and permeability alteration. J Antimicrob Chemother. 2000;46:895-900.
4. Wieczorek P, Sacha P, Hauschild T, Zórawski M, Krawczyk M, Tryniszewska E. Multidrug resistant Acinetobacter baumannii-the role of AdeABC (RND family) efflux pump in resistance to antibiotics. Folia Histochem Cytobiol. 2008;46(3): 257-267.
5. Neuwirth C, Siébor E, Duez JM, Péchinot A, Kazmierczak A. Imipenem resistance in clinical isolates of Proteus mirabilis associated with alterations in penicillin-binding proteins. J Antimicrob Chemother. 1995;36(2):335-342.
6. Thomson JM, Bonomo RA. The threat of antibiotic resistance in Gram-negative pathogenic bacteria: β-lactams in peril! Curr Opin Microbiol. 2005;8(5):518-524.
7. Maltezou HC. Metallo-β-lactamases in Gram-negative bacteria: introducing the era of pan-resistance? Int J Antimicrob Agents. 2009;33(5):405.e1-405e.7.
8. Navon-Venezia S, Chmelnitsky I, Leavitt A, Schwaber MJ, Schwartz D, Carmeli Y. Plasmid-mediated imipenemhydrolyzing enzyme KPC-2 among multiple carbapenem-resistant Escherichia coli clones in Israel. Antimicrob Agents Chemother. 2006;50(9):3098-3101.
9. Queenan AM, Bush K. Carbapenemases: the versatile β-lactamases. Clin Microbiol Rev. 2007;20(3):440-458.
10. Sacha P, Zórawski M, Hauschild T, Wieczorek P, Jaworowska J, Jakoniuk P, Tryniszewska E. The presence of blaIMP genes on plasmids DNA isolated from multidrug-resistant Pseudomonas aeruginosa strains at University Hospital in Bialystok (Poland)-first report. Folia Histochem Cytobiol. 2007; 45(4):405-408.
11. Deshpande LM, Rhomberg PR, Sader HS, Jones RN. Emergence of serine carbapenemases (KPC and SME) among clinical strains of Enterobacteriaceae isolated in the United States Medical Centers: report from the MYSTIC Program (1999-2005). Diagn Microbiol Infect Dis. 2006;56(4):367-372.
12. Sacha P, Wieczorek P, Hauschild T, Zórawski M, Olszañska D, Tryniszewska E. Metallo-β-lactamases of Pseudomonas aeruginosa - a novel mechanism resistance to β-lactam antibiotics. Folia Histochem Cytobiol. 2008;46(2):137-142.
13. Hawkey PM, Jones AM. The changing epidemiology of resistance. J Antimicrob Chemother. 2009;64 Suppl 1:i3-i10.
14. Walther-Rasmussen J, Hoiby N. Class A carbapenemases. J Antimicrob Chemother. 2007;60(3):470-482.
15. Ambler RP. The structure of β-lactamases. Philos Trans R Soc Lond B Biol Sci. 1980;289(1036):321-331.
16. Bush K, Jacoby GA, Medeiros AA. Afunctional classification scheme for β-lactamases and its correlation with molecular structure. Antimicrob Agents Chemother. 1995;39(6):1211-1233.
17. Swarén P, Maveyraud L, Raquet X, Cabantous S, Duez C, Pédelacq JD, Mariotte-Boyer S, Mourey L, Labia R, Nicolas-Chanoine MH, Nordmann P, Frere JM, Samama JP. X-ray analysis of the NMC-A β-lactamase at 1.64-A resolution, a class A carbapenemase with broad substrate specificity. J Biol Chem. 1998;273(41):26714-26721.
18. Sougakoff W, L'Hermite G, Pernot L, Naas T, Guillet V, Nordmann P, Jarlier V, Delettré J. Structure of the imipenemhydrolyzing class A β-lactamase SME-1 from Serratia marcescens. Acta Crystallogr D Biol Crystallogr. 2002;58(Pt 2):267-274.
19. Rasmussen BA, Bush K. Carbapenem-hydrolyzing β-lactamases. Antimicrob Agents Chemother. 1997;41(2):223-232.
20. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001;45(4):1151-1161.
21. Mushtaq S, Ge Y, Livermore DM. Comparative activities of doripenem versus isolates, mutants, and transconjugants of Enterobacteriaceae and Acinetobacter spp. with characterized β-lactamases. Antimicrob Agents Chemother. 2004;48 (4):1313-1319.
22. Giske CG, Sundsfjord AS, Kahlmeter G, Woodford N, Nordmann P, Paterson DL, Cantón R, Walsh TR. Redefining extended-spectrum β-lactamases: balancing science and clinical need. J Antimicrob Chemother. 2009;63(1):1-4.
23. KPC-type β-Lactamases. Available at: http://www.lahey.org/Studies/other.asp. Accessed August 24, 2009.
24. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, Alberti S, Bush K, Tenover FC. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2008;52(2):809.
25. Yigit H, Queenan AM, Rasheed JK, Biddle JW, Domenech-Sanchez A, Alberti S, Bush K, Tenover FC. Carbapenem-resistant strain of Klebsiella oxytoca harboring carbapenem-hydrolyzing β-lactamase KPC-2. Antimicrob Agents Chemother. 2003;47(12):3881-3889.
26. Bennett JW, Herrera ML, Lewis JS 2nd, Wickes BW, Jorgensen JH. KPC-2-producing Enterobacter cloacae and Pseudomonas putida coinfection in a liver transplant recipient. Antimicrob Agents Chemother. 2009;53(1):292-294.
27. Naas T, Nordmann P, Vedel G, Poyart C. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC in a Klebsiella pneumoniae isolate from France. Antimicrob Agents Chemother. 2005;49(10):4423-4424.
28. Villegas MV, Lolans K, Correa A, Suarez CJ, Lopez JA, Vallejo M, Quinn JP; Colombian Nosocomial Resistance Study Group. First detection of the plasmid-mediated class A carbapenemase KPC-2 in clinical isolates of Klebsiella pneumoniae from South America. Antimicrob Agents Chemother. 2006;50(8):2880-2882.
29. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP; Colombian Nosocomial Resistance Study Group. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother. 2007;51(4):1553-1555.
30. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmidmediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007;51(2):763-765.
31. Cai JC, Zhou HW, Zhang R, Chen GX. Emergence of Serratia marcescens, Klebsiella pneumoniae and Escherichia coli isolates possessing the plasmid-mediated carbapenemhydrolyzing β-lactamase KPC-2 in intensive care units of a Chinese hospital. Antimicrob Agents Chemother. 2008;52(6): 2014-2018.
32. Zhang R, Zhou HW, Cai JC, Chen GX. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in carbapenem-resistant Serratia marcescens isolates from Hangzhou, China. J Antimicrob Chemother. 2007;59(3):574-576.
33. Zhang R, Yang L, Cai JC, Zhou HW, Chen GX. High-level carbapenem resistance in a Citrobacter freundii clinical isolate is due to a combination of KPC-2 production and decreased porin expression. J Med Microbiol. 2008;57(Pt 3): 332-337.
34. Marchaim D, Navon-Venezia S, Schwaber MJ, Carmeli Y. Isolation of imipenem-resistant Enterobacter species: emergence of KPC-2 carbapenemase, molecular characterization, epidemiology, and outcomes. Antimicrob Agents Chemother. 2008;52(4):1413-1418.
35. Cuzon G, Naas T, Demachy MC, Nordmann P. Plasmid-mediated carbapenem-hydrolyzing β-lactamase KPC-2 in Klebsiella pneumoniae isolate from Greece. Antimicrob Agents Chemother. 2008;52(2):796-797.
36. Giakoupi P, Maltezou H, Polemis M, Pappa O, Saroglou G, Vatopoulos A; the Greek System for the Surveillance of Antimicrobial Resistance. KPC-2-producing Klebsiella pneumoniae infections in Greek hospitals are mainly due to a hyperepidemic clone. Euro Surveill. 2009;14(21):1-5.
37. Zavascki AP, Machado AB, de Oliveira KR, Superti SV, Pilger DA, Cantarelli VV, Pereira PR, Lieberkmecht AC, Barth AL. KPC-2-producing Enterobacter cloacae in two cities from Southern Brazil. Int J Antimicrob Agents. 2009;34(3): 286-288.
38. Petrella S, Ziental-Gelus N, Mayer C, Renard M, Jarlier V, Sougakoff W. Genetic and structural insights into the dissemination potential of the extremely broad-spectrum class A β-lactamase KPC-2 identified in an Escherichia coli strain and an Enterobacter cloacae strain isolated from the same patient in France. Antimicrob Agents Chemother. 2008;52(10):3725-3736.
39. Woodford N, Tierno PM Jr, Young K, Tysall L, Palepou MF, Ward E, Painter RE, Suber DF, Shungu D, Silver LL, Inglima K, Kornblum J, Livermore DM. Outbreak of Klebsiella pneumoniae producing a new carbapenem-hydrolyzing class A β-lactamase, KPC-3, in a New York Medical Center. Antimicrob Agents Chemother. 2004;48(12):4793-4799.
40. Endimiani A, Carias LL, Hujer AM, Bethel CR, Hujer KM, Perez F, Hutton RA, Fox WR, Hall GS, Jacobs MR, Paterson DL, Rice LB, Jenkins SG, Tenover FC, Bonomo RA. Presence of plasmid-mediated quinolone resistance in Klebsiella pneumoniae isolates possessing blaKPC in the United States. Antimicrob Agents Chemother. 2008;52(7):2680-2682.
41. Bratu S, Landman D, Alam M, Tolentino E, Quale J. Detection of KPC carbapenem-hydrolyzing enzymes in Enterobacter spp. from Brooklyn, New York. Antimicrob Agents Chemother. 2005;49(2):776-778.
42. Deshpande LM, Jones RN, Fritsche TR, Sader HS. Occurrence and characterization of carbapenemase-producing Enterobacteriaceae: report from the SENTRY Antimicrobial Surveillance Program (2000-2004). Microb Drug Resist. 2006;12(4):223-230.
43. Leavitt A, Navon-Venezia S, Chmelnitsky I, Schwaber MJ, Carmeli Y. Emergence of KPC-2 and KPC-3 in carbapenem-resistant Klebsiella pneumoniae strains in an Israeli hospital. Antimicrob Agents Chemother. 2007;51(8):3026-3029.
44. Alba J, Ishii Y, Thomson K, Moland ES, Yamaguchi K. Kinetics study of KPC-3, a plasmid-encoded class A carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother. 2005;49(11):4760-4762.
45. Bratu S, Mooty M, Nichani S, Landman D, Gullans C, Pettinato B, Karumudi U, Tolaney P, Quale J. Emergence of KPC-possessing Klebsiella pneumoniae in Brooklyn, New York: epidemiology and recommendations for detection. Antimi-crob Agents Chemother. 2005;49(7):3018-3020.
46. Moland ES, Hanson ND, Herrera VL, Black JA, Lockhart TJ, Hossain A, Johnson JA, Goering RV, Thomson KS. Plasmid-mediated, carbapenem-hydrolysing β-lactamase, KPC-2, in Klebsiella pneumoniae isolates. J Antimicrob Chemother. 2003;51(3):711-714.
47. Miriagou V, Tzouvelekis LS, Rossiter S, Tzelepi E, Angulo FJ, Whichard JM. Imipenem resistance in a Salmonella clinical strain due to plasmid-mediated class A carbapenemase KPC-2. Antimicrob Agents Chemother. 2003;47(4):1297-1300.
48. Tibbetts R, Frye JG, Marschall J, Warren D, Dunne W. Detection of KPC-2 in a clinical isolate of Proteus mirabilis and first reported description of carbapenemase resistance caused by a KPC β-lactamase in P. mirabilis. J Clin Microbiol. 2008; 46(9):3080-3083.
49. Robledo IE, Moland ES, Aquino EA, Vazquez GJ, Sante MI, Bertran J, and Hanson ND. 2007. First report of a KPC-4 and CTX-M producing K. pneumoniae isolated from Puerto Rico (PR), abstr. C2-1933, p.142. In Abstr. 47th Intersci. Conf. Antimicrob. Agents Chemother. American Society for Microbiology, Washington, DC.
50. Wolter DJ, Kurpiel PM, Woodford N, Palepou MF, Goering RV, Hanson ND. Phenotypic and enzymatic comparative analysis of the novel KPC variant KPC-5 and its evolutionary variants, KPC-2 and KPC-4. Antimicrob Agents Chemother. 2009; 53(2):557-562.
51. Chiang T, Mariano N, Urban C, Colon-Urban R, Grenner L, Eng RH, Huang D, Dholakia H, Identification of carbapenem-resistant Klebsiella pneumoniae harboring KPC enzymes in New Jersey. Microb Drug Resist. 2007;13(4):235-239.
52. Hossain A, Ferraro MJ, Pino RM, Dew RB 3rd, Moland ES, Lockhart TJ, Thomson KS, Goering RV, Hanson ND. Plasmid-mediated carbapenem-hydrolyzing enzyme KPC-2 in an Enterobacter spp. Antimicrob Agents Chemother. 2004; 48(11):4438-4440.
53. Naas T, Cuzon G, Villegas MV, Lartigue MF, Quinn JP, Nordmann P. Genetic structures at the origin of acquisition of the β-lactamase blaKPC gene. Antimicrob Agents Chemother. 2008;52(4):1257-1263.
54. Mendes RE, Bell JM, Turnidge JD, Yang Q, Yu Y, Sun Z, Jones RN. Carbapenem-resistant isolates of Klebsiella pneumoniae in China and detection of a conjugative plasmid (blaKPC-2 plus qnrB4) and a blaIMP-4 gene. Antimicrob Agents Chemother. 2008;52(2):798-799.
55. Chmelnitsky I, Navon-Venezia S, Strahilevitz J, Carmeli Y. Plasmid-mediated qnrB2 and carbapenemase gene blaKPC-2 carried on the same plasmid in carbapenem-resistant ciprofloxacin-susceptible Enterobacter cloacae isolates. Antimicrob Agents Chemother. 2008;52(8):2962-2965.
56. Monteiro J, Santos AF, Asensi MD, Peirano G, Gales AC. First report of KPC-2-producing Klebsiella pneumoniae strains in Brazil. Antimicrob Agents Chemother. 2009;53(1): 333-334.
57. Rice LB, Carias LL, Hutton RA, Rudin SD, Endimiani A, Bonomo RA. The KQ element, a complex genetic region conferring transferable resistance to carbapenems, aminoglycosides, and fluoroquinolones in Klebsiella pneumoniae. Antimicrob Agents Chemother. 2008;52(9):3427-3429.
58. Rasheed JK, Biddle JW, Anderson KF, Washer L, Chenoweth C, Perrin J, Newton DW, Patel JB. Detection of the Klebsiella pneumoniae carbapenemase type 2 carbapenem-hydrolyzing enzyme in clinical isolates of Citrobacter freundii and K. oxytoca carrying a common plasmid. J Clin Microbiol. 2008; 46(6):2066-2069.
59. Naas T, Vandel L, Sougakoff W, Livermore DM, Nordmann P. Cloning and sequence analysis of the gene for a carbapenem-hydrolyzing class A β-lactamase, Sme-1, from Serratia marcescens S6. Antimicrob Agents Chemother. 1994;38(6): 1262-70.
60. Nordmann P. Trends in β-lactam resistance among Enterobacteriaceae. Clin Infect Dis. 1998;27 Suppl 1:S100-S106.
61. Henriques I, Moura A, Alves A, Saavedra MJ, Correia A. Molecular characterization of a carbapenem-hydrolyzing class A β-lactamase, SFC-1, from Serratia fonticola UTAD54. Antimicrob Agents Chemother. 2004;48(6):2321-2324.
62. Sarno R, McGillivary G, Sherratt DJ, Actis LA, Tolmasky ME. Complete nucleotide sequence of Klebsiella pneumoniae multiresistance plasmid pJHCMW1. Antimicrob Agents Chemother. 2002;46(11):3422-3427.
63. Bratu S, Landman D, Haag R, Recco R, Eramo A, Alam M, Quale J. Rapid spread of carbapenem-resistant in New York City: a new threat to our antibiotic armamentarium. Arch Intern Med. 2005;165(12):1430-1435.
64. Lomaestro BM, Tobin EH, Shang W, Gootz T. The spread of Klebsiella pneumoniae carbapenemase-producing K. pneumoniae to upstate New York. Clin Infect Dis. 2006;43(3):e26-e28.
65. Bratu S, Brooks S, Burney S, Kochar S, Gupta J, Landman D, Quale J. Detection and spread of Escherichia coli possessing the plasmid-borne carbapenemase KPC-2 in Brooklyn, New York. Clin Infect Dis. 2007;44(7):972-975.
66. Nadkarni AS, Schliep T, Khan L, Zeana CB. Cluster of bloodstream infections caused by KPC-2 carbapenemase-producing Klebsiella pneumoniae in Manhattan. Am J Infect Control. 2009;37(2):121-126.
67. Marschall J, Tibbetts RJ, Dunne WM Jr, Frye JG, Fraser VJ, Warren DK. Presence of the KPC carbapenemase gene in Enterobacteriaceae causing bacteremia and its correlation with in vitro carbapenem susceptibility. J Clin Microbiol. 2009;47(1):239-241.
68. Mathers AJ, Cox HL, Bonatti H, Kitchel B, Brassinga AK, Wispelwey B, Sawyer RG, Pruett TL, Hazen KC, Patel JB, Sifri CD. Fatal cross infection by carbapenem-resistant Klebsiella in two liver transplant recipients. Transpl Infect Dis. 2009;11(3):257-65.
69. Anderson KF, Lonsway DR, Rasheed JK, Biddle J, Jensen B, McDougal LK, Carey RB, Thompson A, Stocker S, Limbago B, Patel JB. Evaluation of methods to identify the Klebsiella pneumoniae carbapenemase in Enterobacteriaceae. J Clin Microbiol. 2007;45(8):2723-2725.
70. Doi Y, Potoski BA, Adams-Haduch JM, Sidjabat HE, Pasculle AW, Paterson DL. Simple disk-based method for detection of Klebsiella pneumoniae carbapenemase-type β-lactamase by use of a boronic acid compound. J Clin Microbiol. 2008; 46(12):4083-4086.
71. Tsakris A, Kristo I, Poulou A, Themeli-Digalaki K, Ikonomidis A, Petropoulou D, Pournaras S, Sofianou D. Evaluation of boronic acid disk tests for differentiating KPC-possessing Klebsiella pneumoniae isolates in the clinical laboratory. J Clin Microbiol. 2009;47(2):362-367.
72. Tenover FC, Kalsi RK, Williams PP, Carey RB, Stocker S, Lonsway D, Rasheed JK, Biddle JW, McGowan JE Jr, Hanna B. Carbapenem resistance in Klebsiella pneumoniae not detected by automated susceptibility testing. Emerg Infect Dis. 2006;12(8):1209-1213.
73. Bratu S, Tolaney P, Karumudi U, Quale J, Mooty M, Nichani S, Landman D. Carbapenemase-producing Klebsiella pneumoniae in Brooklyn, NY: molecular epidemiology and in vitro activity of polymyxin B and other agents. J Antimicrob Chemother. 2005;56(1):128-132.
74. Hawser SP, Bouchillon SK, Hoban DJ, Hackel M, Johnson JL, Badal RE. Klebsiella pneumoniae isolates possessing KPC β-lactamase in Israel, Puerto Rico, Colombia and Greece. Int J Antimicrob Agents. 2009;34(4):384-385.
75. Stachyra T, Levasseur P, Péchereau MC, Girard AM, Claudon M, Miossec C, Black MT. In vitro activity of the β-lactamase inhibitor NXL104 against KPC-2 carbapenemase and Enterobacteriaceae expressing KPC carbapenemases. J Antimicrob Chemother. 2009;64(2):326-329.